The stock prices can overshoot to the downside or upside in major way especially when investing in this neck of the woods. Clinical trials are moving along as is expansion , EU MDR approval is expected by about September this year. TGA considers that data in the application for regulatory approval in Australia as the TGA takes EU MDR approval seriously. FDA approval process is moving along.
The main play here imo is that this is being primed for a take over with a larger pharma who can monetize this device much better than Oncosil can . I think Oncosil know this. Bullish changes to T20 , institutional placement , larger investors buying and others increasing holdings could assist a much better deal for investors.
OSL Price at posting:
1.2¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)